(Q54377510)

29 May 2018

title

Antimicrobial susceptibility of intra-abdominal gram-negative bacilli from Europe: SMART Europe 2008. (English)

1 reference

29 May 2018

author name string

S Hawser

1

1 reference

29 May 2018

D Hoban

2

1 reference

29 May 2018

S Bouchillon

3

1 reference

29 May 2018

R Badal

4

1 reference

29 May 2018

Y Carmeli

5

1 reference

29 May 2018

P Hawkey

6

1 reference

29 May 2018

publication date

16 October 2010

1 reference

29 May 2018

European Journal of Clinical Microbiology & Infectious Diseases

published in

1 reference

29 May 2018

volume

30

1 reference

29 May 2018

issue

2

1 reference

29 May 2018

page(s)

173-179

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s10096-010-1066-0

exact match

0 references

cites work

Healthcare-associated Infections: epidemiology, prevention, and therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Antimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

An outbreak of infection due to beta-Lactamase Klebsiella pneumoniae Carbapenemase 2-producing K. pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10096-010-1066-0

EUCAST technical note on Amphotericin B.

21 January 2018

1 reference

12 December 2020

Increasing multidrug resistance and limited treatment options: situation and initiatives in Europe.

1 reference

12 December 2020

Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe

1 reference

12 December 2020

Intra-abdominal infections

1 reference

12 December 2020

Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe.

1 reference

12 December 2020

10.1007/S10096-010-1066-0

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018